Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Remitly Global | RELY | Sep 30, 2024 | 13.39 | -1.90 |
Renaissance Ipo ETF | IPO | Sep 30, 2024 | 42.88 | -0.53 |
RenaissanceRe | RNR | Sep 30, 2024 | 272.40 | +1.11 |
RenaissanceRe G Pref | RNR-G | Sep 30, 2024 | 18.54 | -0.86 |
RenaissanceRe Holding F Pref | RNR-F | Sep 30, 2024 | 24.77 | -0.76 |
Renalytix ADR | RNLX | Sep 30, 2024 | 0.21 | -20.13 |
Renasant | RNST | Sep 30, 2024 | 32.50 | +1.47 |
Reneo Pharmaceuticals | RPHM | Sep 30, 2024 | 1.70 | +2.41 |
ReNew Energy Global A Shares | RNW | Sep 30, 2024 | 6.29 | 0.00 |
Renn Fund | RCG | Sep 30, 2024 | 2.12 | +4.95 |
Renovaro Biosciences | RENB | Sep 30, 2024 | 0.48 | -1.97 |
RenovoRx | RNXT | Sep 30, 2024 | 1.06 | 0.00 |
Rent The Runway A | RENT | Sep 30, 2024 | 9.64 | -4.74 |
Rentokil Initial ADR | RTO | Sep 30, 2024 | 24.93 | -2.69 |
Repare Therapeutics | RPTX | Sep 30, 2024 | 3.44 | 0.00 |
Repay A | RPAY | Sep 30, 2024 | 8.16 | +0.25 |
Repligen | RGEN | Sep 30, 2024 | 148.82 | +1.98 |
Replimune Group | REPL | Sep 30, 2024 | 10.96 | -1.79 |
ReposiTrak | TRAK | Sep 30, 2024 | 18.47 | +4.29 |
Republic Bancorp A | RBCAA | Sep 30, 2024 | 65.30 | +1.63 |
Republic Services | RSG | Sep 30, 2024 | 200.84 | +0.73 |
Research Frontiers | REFR | Sep 30, 2024 | 2.19 | -1.79 |
Research Solutions | RSSS | Sep 30, 2024 | 2.73 | -0.73 |
Reservoir Media | RSVR | Sep 30, 2024 | 8.11 | +3.58 |
ReShape Lifesciences | RSLS | Sep 30, 2024 | 5.65 | -0.35 |
Resideo Technologies | REZI | Sep 30, 2024 | 20.14 | +0.55 |
ResMed | RMD | Sep 30, 2024 | 244.12 | +2.14 |
Resources Connection | RGP | Sep 30, 2024 | 9.70 | +2.54 |
Restaurant Brands International | QSR | Sep 30, 2024 | 72.12 | +1.18 |
Retail Bull 3X Direxion | RETL | Sep 30, 2024 | 9.52 | -0.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.